Boenning & Scattergood, Inc. Jazz Pharmaceuticals PLC Transaction History
Boenning & Scattergood, Inc.
- $622 Million
- Q4 2022
A detailed history of Boenning & Scattergood, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Boenning & Scattergood, Inc. holds 3,448 shares of JAZZ stock, worth $420,035. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,448
Previous 3,448
-0.0%
Holding current value
$420,035
Previous $460,000
16.74%
% of portfolio
0.09%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding JAZZ
# of Institutions
514Shares Held
57.6MCall Options Held
188KPut Options Held
133K-
Black Rock Inc. New York, NY6.15MShares$749 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$744 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.49MShares$304 Million0.6% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.1MShares$256 Million0.56% of portfolio
-
State Street Corp Boston, MA1.95MShares$237 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.64B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...